search
Back to results

Neonatal Wireless Monitoring System for Intensive Care

Primary Purpose

Preterm Infant, Infant, Newborn, Low; Birthweight, Extremely (999 Grams or Less)

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Wireless vital sign monitoring - comparative
Wireless vital sign monitoring - usability
Sponsored by
Cambridge University Hospitals NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Preterm Infant focused on measuring Patient monitoring, Medical device, Wireless

Eligibility Criteria

undefined - 6 Months (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

(i) Babies being cared for on the NICU at Addenbrooke's Hospital (ii) Written, informed parental consent

Exclusion Criteria:

(i) Known to have an intolerance to silicone or silicone gel adhesives. (ii) Has a pacemaker, or other implanted electronic device

Sites / Locations

  • Cambridge University Hospitals NHS Foundation TrustRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Comparative assessment of data quality

Usability

Arm Description

Quantitative comparison between the current wired system and the new wireless system

Qualitative assessment of the new wireless system

Outcomes

Primary Outcome Measures

Mean (SD) difference in ECG waveform data
comparison of data between wired (standard care) and wireless system

Secondary Outcome Measures

Impact on care: qualitative interviews with parents and staff
Qualitative interviews
Impact on care: qualitative questionnaire with parents and staff
Questionnaire

Full Information

First Posted
January 12, 2020
Last Updated
January 11, 2021
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Collaborators
University of Cambridge
search

1. Study Identification

Unique Protocol Identification Number
NCT04241263
Brief Title
Neonatal Wireless Monitoring System for Intensive Care
Official Title
Feasibility Study of a Neonatal Wireless Transmission System (NeWTS)
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2020 (Actual)
Primary Completion Date
July 31, 2021 (Anticipated)
Study Completion Date
July 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cambridge University Hospitals NHS Foundation Trust
Collaborators
University of Cambridge

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Babies who require intensive care need to have their heart rate, oxygen levels and temperature measured continuously using specially designed monitors. These monitors allow the clinical team to constantly assess the baby and see if they are becoming unwell. However, these monitors each have separate wires to connect them to the baby. Another important part of care in these babies is being able to allow parents to hold their babies, getting them out of their incubators to be cuddled. This is called Kangaroo care and has been shown to impact on long term health for both babies and parents. We have designed a system to free babies of the wires that tether them to the monitors. This system has been tested in adults and we now want to test them on the babies. There are two study parts with two different questions: How good is the data? This will compare the new wireless system with the existing system. Babies will have both standard wired monitors and the new wireless monitor on at the same time so we can compare the data to see how good is the quality of the data collected on the new system. What do parents and staff think about the wireless system during Kangaroo care? Babies who no longer need monitoring (but who previously had been monitored with the wired system), will have the wireless system attached and the parent will take their baby from the cot for Kangaroo Care. After the baby has been placed back in the cot, we will conduct interviews with the parent and the nurse to find out what they thought of the new system. We hope this will help the investigators to understand about how good the data is we collect and how we might be able to improve the system.
Detailed Description
Summary of study design This is a single-center study recruiting from the neonatal intensive care unit (NICU) at Addenbrooke's Hospital, Cambridge. There are 2 study parts: Quantitative assessment of the accuracy of the new system in comparison with standard clinical monitoring systems Qualitative Assessment of parent and staff views of caring for babies with the new system in comparison with conventional clinical monitoring systems Quantitative study arm Study population Up to 24 participants will be recruited from the Addenbrooke's Hospital NICU. The participants will be recruited from three groups, defined by the BAPM Categories of Care The population size has been selected to include sufficient babies to collect a reasonable amount of data to ascertain, with confidence, our defined outcomes. Furthermore, the data should come from across the range of variables seen in babies requiring intensive care while limiting exposure of the infants at most risk. The study will be performed in a stepwise fashion, starting with those infants requiring lower dependency care. Inclusion criteria Babies being cared for on the NICU at Addenbrookes Hospital Written, informed parental consent Exclusion criteria Known to have an intolerance to silicone or silicone gel adhesives. Has a pacemaker or other implanted electronic device. Planned procedures Participants will have the newly developed wireless sensors for ECG, pulse oximetry, and temperature attached adjacent to the current clinical, wired sensors. Once the application sites have been identified and prepared, the sensors will be placed on the baby by an appropriately trained individual. The wireless receiver will connect to a separate patient monitor to log the comparative data. This study monitor will be covered and silenced such that data will not be visible to the clinical team, and it will not be possible to confuse the study monitor from the 'clinical' monitor. The sensors will be in place for a period of up to 24 hours. After this period, the study sensors will be removed, and the site inspected by a member of the research team and scored using the standard tissue viability scoring system already in use on the unit. The sensors will be disposed of in keeping with the unit and Trust policy. After the study intervention, a questionnaire will be given to the nurse caring for the baby to determine their views on the wireless system. Data collection Data will be collected from both the study monitor and the 'clinical' monitor. The data are formed of two types: parameter data and waveform data. Parameter data has a two-second interval. The waveform data has a period of approximately 4ms. Qualitative study arm Study population Up to 10 participants will be recruited from the Addenbrooke's Hospital. This is in line with other studies with similar cohorts and balances the need to obtain a range of views and experiences, with the imposition on parents' time in such an environment. Inclusion criteria BAPM level transitional care babies who do not clinically require vital sign monitoring. The baby has had vital sign monitoring at some point during their stay on the unit. Written, informed parental consent Exclusion criteria Known to have an intolerance to silicone or silicone gel adhesives. Has a pacemaker or other implanted electronic medical device. Planned procedure Babies who are not indicated for vital sign monitoring will have the wireless monitoring system attached. Once the application sites have been identified and prepared, the sensors will be placed on the baby by an appropriately trained individual. The wireless receiver will connect to the study monitor to log the vital sign data, and all alarms will be silenced. The monitor will be covered and silenced such that it will not impact on clinical care. The baby will be transferred from the cot/incubator to the parent for kangaroo care as per standard NICU procedure. The parent and baby will remain in contact for as long as the parent is comfortable, and the baby remains stable and in keeping with unit policy and procedures. The baby will then be transferred back to the cot, and monitoring will be removed. Semi-structured interviews lasting approximately 30 minutes will then be conducted with, (i) the nurse, and (ii) the parent(s). These interviews will focus on previous experiences with vital sign monitoring systems, and their experience of using the new wireless system.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Infant, Infant, Newborn, Low; Birthweight, Extremely (999 Grams or Less)
Keywords
Patient monitoring, Medical device, Wireless

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
This is a feasibility study but there are two arms and the babies, parents and staff will all be considered participants -it will be approximately 20 families recruited
Allocation
Non-Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Comparative assessment of data quality
Arm Type
Other
Arm Description
Quantitative comparison between the current wired system and the new wireless system
Arm Title
Usability
Arm Type
Other
Arm Description
Qualitative assessment of the new wireless system
Intervention Type
Device
Intervention Name(s)
Wireless vital sign monitoring - comparative
Intervention Description
Participants who currently have vital sign monitoring will, in addition, have the wireless system attached. We will then collect up to 24 hours of vital sign data from both systems, which will allow us to make direct comparisons between them.
Intervention Type
Device
Intervention Name(s)
Wireless vital sign monitoring - usability
Intervention Description
Babies will be recruited who do not currently require vital sign monitoring. The wireless system will be attached to these babies by nurses who have been trained in its use. A parent will then be asked to perform Kangaroo Care for as long as they feel comfortable. After the baby is placed back in its cot, and the sensors have been removed, we will conduct (separate) interviews with the nurse and the parent on the neonatal intensive care unit (NICU).
Primary Outcome Measure Information:
Title
Mean (SD) difference in ECG waveform data
Description
comparison of data between wired (standard care) and wireless system
Time Frame
Up to 24 hours of monitoring data per participant
Secondary Outcome Measure Information:
Title
Impact on care: qualitative interviews with parents and staff
Description
Qualitative interviews
Time Frame
immediately post intervention
Title
Impact on care: qualitative questionnaire with parents and staff
Description
Questionnaire
Time Frame
immediately post intervention

10. Eligibility

Sex
All
Maximum Age & Unit of Time
6 Months
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: (i) Babies being cared for on the NICU at Addenbrooke's Hospital (ii) Written, informed parental consent Exclusion Criteria: (i) Known to have an intolerance to silicone or silicone gel adhesives. (ii) Has a pacemaker, or other implanted electronic device
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kathryn Beardsall, MRCP
Phone
01223746791
Email
kb274@cam.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
kathryn beardsall
Organizational Affiliation
University of Cambridge
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cambridge University Hospitals NHS Foundation Trust
City
Cambridge
State/Province
Cambridgeshire
ZIP/Postal Code
CB2 0QQ
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kathryn Beardsall
Email
kb274@medschl.cam.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Neonatal Wireless Monitoring System for Intensive Care

We'll reach out to this number within 24 hrs